[1]聂 志.吸入用沙丁胺醇联合布地奈德对COPD急性加重期的作用[J].医学信息,2019,32(22):105-106.[doi:10.3969/j.issn.1006-1959.2019.22.033]
　NIE Zhi.Effect of Inhaled Salbutamol Combined with Budesonide on Acute Exacerbation of COPD[J].Journal of Medical Information,2019,32(22):105-106.[doi:10.3969/j.issn.1006-1959.2019.22.033]
点击复制

吸入用沙丁胺醇联合布地奈德对COPD急性加重期的作用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年22期
页码:
105-106
栏目:
临床研究
出版日期:
2019-11-15

文章信息/Info

Title:
Effect of Inhaled Salbutamol Combined with Budesonide on Acute Exacerbation of COPD
文章编号:
1006-1959（2019）22-0105-02
作者:
聂 志
（赣州市大余县人民医院内二科，江西 大余 341500）
Author(s):
NIE Zhi
(Department of Internal Medicine,Subject Two,Dayu County People's Hospital,Dayu 341500,Jiangxi,China)
关键词:
COPD; 急性加重期; 沙丁胺醇; 布地奈德
Keywords:
COPD; Acute exacerbation period; Salbutamol; Budesonide
分类号:
R563
DOI:
10.3969/j.issn.1006-1959.2019.22.033
文献标志码:
A
摘要:
目的 观察吸入用沙丁胺醇联合布地奈德对COPD急性加重期的作用。方法 选取2015年1月~2017年1月我院治疗的86例COPD急性加重期患者，随机分为观察组和对照组，每组43例。对照组在常规治疗的基础上雾化吸入布地奈德，观察组在对照组的基础上吸入用沙丁胺醇。比较两组治疗前后用力肺活量（FVC）、第1秒用力呼气容积（FEV1），临床治疗效果。结果 治疗后，两组FVC、FEV1均高于治疗前，观察组FVC、FEV1分别为（2.08±0.57）L、（1.97±0.43）L，高于对照组的（1.69±0.49）L、（1.47±0.36）L，差异有统计学意义（P＜0.05）；观察组治疗有效率为97.67%，高于对照组的76.74%，差异有统计学意义（P＜0.05）。结论 吸入用沙丁胺醇联合布地奈德有助于改善COPD急性期患者FVC、FEV1，具有较高的疗效。
Abstract:
Objective To observe the effect of inhaled salbutamol combined with budesonide on acute exacerbation of COPD. Methods 86 patients with acute exacerbation of COPD who were admitted to hospital from January 2015 to January 2017 were randomly divided into observation group and control group, with 43 cases in each group. The control group was inhaled budesonide on the basis of conventional treatment, and the observation group inhaled salbutamol on the basis of the control group. The forced vital capacity (FVC) and the forced expiratory volume in the first second (FEV1) before and after treatment were compared between the two groups. Results After treatment, FVC and FEV1 were higher than those before treatment. The FVC and FEV1 of the observation group were (2.08±0.57)L and (1.97±0.43)L, respectively, which was higher than that of the control group (1.69±0.49)L, (1.47±0.36) L, the difference also had statistical significance (P<0.05); the effective rate of observation group was 97.67%, which was higher than 76.74% of the control group, the difference was statistically significant (P<0.05).Conclusion Salbutamol inhalation combined with budesonide can improve the FVC and FEV1 in patients with acute COPD and improve the curative effect. It is worthy of application.

参考文献/References:

[1]蔡惠东,潘剑蓉.沙丁胺醇联合布地奈德氧气雾化吸入与超声雾化吸入对小儿肺炎疗效及炎症因子的改善对比探析[J].检验医学与临床,2017,14(18):2745-2747. [2]杨洪涛,陈哲,宋爱芹.雾化吸入布地奈德联合沙丁胺醇治疗慢性阻塞性肺疾病急性加重期的疗效及对肺功能相关指标的影响[J].实用临床医药杂志,2017,21(15):118-119. [3]黄诚文,孙印,勾建强,等.正五聚蛋白-3对COPD急性加重期的预测价值[J].国际呼吸杂志,2017,37(21):1614-1617. [4]杨振英,王亚坤,周礼清,等.糖皮质激素类联合肾上腺素能β激动剂对慢性阻塞性肺疾病急性加重期患者的疗效分析[J].安徽医药,2018,22(1):151-155. [5]文艳梅,徐治波,苟冶然.甲基泼尼松龙与吸入性布地奈德混悬液对老年COPD急性加重期患者降钙素原和C反应蛋白水平的影响[J].西部医学,2017,29(1):78-81. [6]朱海花.沙丁胺醇和布地奈德联合氨溴索雾化治疗慢性阻塞性肺疾病急性加重期患者的疗效[J].医疗装备,2017,30(21):125-126.

相似文献/References:

[1]任庆玲.聚焦解决模式对慢阻肺患者主要照顾者的 照顾负担及负性情绪影响的研究[J].医学信息,2018,31(07):162.[doi:10.3969/j.issn.1006-1959.2018.07.057]
　REN Qing-ling.Study on the Effect of Focus-resolving Model on the Burden of Care and Negative Emotions of Primary Caregivers in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(22):162.[doi:10.3969/j.issn.1006-1959.2018.07.057]
[2]刘 颖,杨志高,李慧琼,等.肠内联合肠外营养与肠内营养支持治疗COPD机械通气患者疗效比较的Meta分析[J].医学信息,2022,35(10):98.[doi:10.3969/j.issn.1006-1959.2022.10.024]
　LIU Ying,YANG Zhi-gao,LI Hui-qiong,et al.Meta-analysis of the Efficacy of Enteral Combined Parenteral Nutrition and Enteral Nutrition Support in the Treatment of COPD Patients with Mechanical Ventilation[J].Journal of Medical Information,2022,35(22):98.[doi:10.3969/j.issn.1006-1959.2022.10.024]
[3]刘怡彤,马利军.基于“互联网+”的移动医疗技术在慢性阻塞性肺病稳定期管理的应用及问题研究[J].医学信息,2019,32(06):38.[doi:10.3969/j.issn.1006-1959.2019.06.014]
　LIU Yi-tong,MA Li-jun.Application and Problem Research of Mobile Medical Technology Based on"Internet +"in Stable Period Management of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2019,32(22):38.[doi:10.3969/j.issn.1006-1959.2019.06.014]
[4]林 杨,苏志强,鲍 靖,等.ICF核心分类联合mMRC用于COPD患者康复效果的研究[J].医学信息,2019,32(03):175.[doi:10.3969/j.issn.1006-1959.2019.03.060]
　LIN Yang,SU Zhi-qiang,BAO Jing,et al.Effect of ICF Core Classification Combined with mMRC on Rehabilitation of COPD Patients[J].Journal of Medical Information,2019,32(22):175.[doi:10.3969/j.issn.1006-1959.2019.03.060]
[5]梁雪梅,蔡晓玉,王 真,等.综合护理措施对无创呼吸机治疗COPD合并呼吸衰竭的Meta分析[J].医学信息,2019,32(05):91.[doi:10.3969/j.issn.1006-1959.2019.05.027]
　LIANG Xue-mei,CAI Xiao-yu,WANG Zhen,et al.Meta-analysis of Comprehensive Nursing Measures for Non-invasive Ventilator in the Treatment of COPD with Respiratory Failure[J].Journal of Medical Information,2019,32(22):91.[doi:10.3969/j.issn.1006-1959.2019.05.027]
[6]张佳佳,李 庆,王 同.中性粒细胞CD64指数指导慢性阻塞性肺疾病急性加重期抗生素应用的探讨[J].医学信息,2019,32(07):78.[doi:10.3969/j.issn.1006-1959.2019.07.023]
　ZHANG Jia-jia,LI Qing,WANG Tong.The Application of Neutrophil CD64 Index in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2019,32(22):78.[doi:10.3969/j.issn.1006-1959.2019.07.023]
[7]吴 鹏,徐 超,曲 红.线性周期化训练和非线性周期化训练对慢性阻塞性肺疾病患者的影响[J].医学信息,2019,32(09):88.[doi:10.3969/j.issn.1006-1959.2019.09.028]
　WU Peng,XU Chao,QU Hong.Effects of Linear Periodic Training and Nonlinear Periodic Training on Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2019,32(22):88.[doi:10.3969/j.issn.1006-1959.2019.09.028]
[8]马宏境,刘 彬.慢性阻塞性肺疾病发病机制的研究[J].医学信息,2019,32(10):50.[doi:10.3969/j.issn.1006-1959.2019.10.018]
　MA Hong-jing,LIU Bin.Study on the Pathogenesis of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2019,32(22):50.[doi:10.3969/j.issn.1006-1959.2019.10.018]
[9]高小燕,陈 蓉,卢慧宇.血糖控制水平对COPD伴2型糖尿病患者 肺功能及其预后的影响[J].医学信息,2019,32(16):76.[doi:10.3969/j.issn.1006-1959.2019.16.023]
　GAO Xiao-yan,CHEN Rong,LU Hui-yu.Effect of Blood Glucose Control Level on Pulmonary Function and Prognosis in Patients with COPD and Type 2 Diabetes[J].Journal of Medical Information,2019,32(22):76.[doi:10.3969/j.issn.1006-1959.2019.16.023]
[10]刘太容,秦尔奇,刘小苹,等.穴位按摩联合六字诀呼吸操应用于慢性阻塞性肺疾病 急性加重期患者中的疗效[J].医学信息,2019,32(16):151.[doi:10.3969/j.issn.1006-1959.2019.16.051]
　LIU Tai-rong,QIN Er-qi,LIU Xiao-ping,et al.Therapeutic Effect of Acupoint Massage Combined with Six-character Respiration in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2019,32(22):151.[doi:10.3969/j.issn.1006-1959.2019.16.051]
[11]马建娟.布地奈德联合异丙托溴铵雾化治疗COPD 急性加重期的效果评价[J].医学信息,2018,31(07):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
　MA Jian-juan.Efficacy Evaluation of Budesonide Combined with Ipratropium Bromide in Treatment of Acute Exacerbation of COPD[J].Journal of Medical Information,2018,31(22):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]

更新日期/Last Update: 2019-11-15